Applied Health Economics and Health Policy

Article	Citations
Cost-Effective and Sustainable Drug Use in Hospitals: A Systematic and Practice-Based Approach	86
Cost-Effectiveness of Perinatal Depression Screening: A Scoping Review	53
Assessing the Direct Impact of Death on Discrete Choice Experiment Utilities	35
Developing a Framework for the Health Technology Assessment of Histology-independent Precision Oncology Therapies	34
Therapy, Pills and Unmet Needs for Financial Reasons: Socioeconomic Inequalities and Inequities in Access to Mental Health Care in Spain 2014–2020	33
Population Norms for SF-6Dv2 and EQ-5D-5L in China	31
Deterministic and Probabilistic Analysis of a Simple Markov Model: How Different Could They Be?	30
Cost-Effectiveness and Value of Information Analyses of Caplacizumab for the Treatment of Thrombotic Thrombocytopenic Purpura in Brazil	28
Approaches to Incorporation of Preferences into Health Economic Models of Genomic Medicine: A Critical Interpretive Synthesis and Conceptual Framework	28
Exploratory Approach to Incorporating Carbon Footprint in Health Technology Assessment (HTA) Modelling: Cost-Effectiveness Analysis of Health Interventions in the United Kingdom	28
A Guideline-Implementation Intervention to Improve the Management of Low Back Pain in Primary Care: A Difference-in-Difference-in-Differences Analysis	24
Psychometric Evaluation of the PedsQL GCS and CHU9D in Australian Children and Adolescents with Common Chronic Health Conditions	24
The Effect of Price Changes and Teaspoon Labelling on Intention to Purchase Sugar-Sweetened Beverages: A Discrete Choice Experiment	23
Applications of Behavioral Economics to Pharmaceutical Policymaking: A Scoping Review with Implications for Best-Value Biological Medicines	22
Economic Evaluation of Evusheld for Preexposure Prevention of COVID-19 in High-Risk Populations: Early Evidence from Thailand	22
Correction to: The Cost Effectiveness of Taxation of Sugary Foods and Beverages: A Systematic Review of Economic Evaluations	20
A Systematic Review of the World’s Largest Government Sponsored Health Insurance Scheme for 500 Million Beneficiaries in India: Pradhan Mantri Jan Arogya Yojana	19
Economic Evaluation Evidence for Resource-Allocation Decision Making: Bridging the Gap for Local Decision Makers Using English Case Studies	18
How is Value Defined in Molecular Testing in Cancer? A Scoping Review	18
Financing Comprehensive Immunization Services in Lao PDR: A Fiscal Space Analysis From a Public Policy Perspective	18
Local Level Economic Evaluation: What is it? What is its Value? Is it Sustainable?	18
Avoiding Opportunity Cost Neglect in Cost-Effectiveness Analysis for Health Technology Assessment	17
The Economic Cost of Rising Non-communicable Diseases in India: A Systematic Literature Review of Methods and Estimates	15
Estimating the Health Effects of Expansions in Health Expenditure in Indonesia: A Dynamic Panel Data Approach	14
Correction: Deterministic and Probabilistic Analysis of a Simple Markov Model: How Different Could They Be?	14

Avoiding Trouble Ahead: Lessons Learned and Suggestions for Economic Evaluations of COVID-19 Vaccines	14
Including Pharmaceuticals in Bundled Payments	14
How to Cost the Implementation of Major System Change for Economic Evaluations: Case Study Using Reconfigurations of Specialist Cancer Surgery in Part of London, England	14
Correction to: Cost Effectiveness of Allogeneic Umbilical Cord Blood-Derived Mesenchymal Stem Cells in Patients with Knee Osteoarthritis	14
10 Years of AMNOG: What is the Willingness-to-Pay for Pharmaceuticals in Germany?	14
Economic Effects of Fixed-Dose Versus Loose-Dose Combination Therapy for Type 2 Diabetes Patients	13
Scope Issue in Contingent Valuation Studies of the COVID-19 Vaccine: The Case of China	13
Methodological Note: Reporting Deterministic versus Probabilistic Results of Markov, Partitioned Survival and Other Non-Linear Models	13
How Much Should be Invested in Lung Care Across the WHO European Region? Applying a Monetary Value to Disability-Adjusted Life-Years Within the International Respiratory Coalition’s Lung Facts	13
Social Costs of Smoking in the Czech Republic	12
Cost-Effectiveness of Bosutinib for the Treatment of Adult Patients with Chronic Phase Chronic Myeloid Leukemia in the Second-Line Setting	12
Budget Impact Analysis of the Introduction of Subcutaneous Infliximab (CT-P13 SC) for the Treatment of Rheumatoid Arthritis in the United Kingdom	12
The Impact of Unrelated Future Medical Costs on Economic Evaluation Outcomes for Different Models of Diabetes	12
Valuation of Costs in Health Economics During Financial and Economic Crises: A Case Study from Lebanon	12
Indirect and Direct Mapping of the Cancer-Specific EORTC QLQ-C30 onto EQ-5D-5L Utility Scores	11
Contextual Factors that Influence Antibiotic Prescribing: A Discrete Choice Experiment of GP Registrars	11
Development of a Health Technology Assessment Quality Appraisal Checklist (HTA-QAC) for India	11
Measures of Performance and Clinical Superiority Thresholds for ‘Test-and-treat’ Predictive Biomarkers	10
Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) Statement: Updated Reporting Guidance for Health Economic Evaluations	10
Correction to: Different Frameworks, Similar Results? Head-to-Head Comparison of the Generic Preference-Based Health-Outcome Measures CS-Base and EQ-5D-5L	10
Cost-Effectiveness and Budget Impact Analysis of Implementing a 'Soft Opt-Out' System for Kidney Donation in Australia	9
Guiding Health Resource Allocation: Using Population Net Health Benefit to Align Disease Burden with Cost Effectiveness for Informed Decision Making	9
Is Economic Evaluation and Care Commissioning Focused on Achieving the Same Outcomes? Resource-Allocation Considerations and Challenges Using England as a Case Study	9
Supply-Side Cost-Effectiveness Thresholds: Questions for Evidence-Based Policy	9
Machine Learning-Assisted Health Economics and Policy Reviews: A Comparative Assessment	8
Value and Price of Multi-indication Cancer Drugs in the USA, Germany, France, England, Canada, Australia, and Scotland	8
Herd Immunity Effects in Cost-Effectiveness Analyses among Low- and Middle-Income Countries	8
Young People’s Preferences for Web-Based Mental Health Interventions for Managing Anxiety and Depression: A Discrete Choice Experiment	8
Projected Impact on Labour Productivity Costs of Cancer-Related Premature Mortality in Europe 2018–2040	8
A Systematic Review of Cost-Effectiveness Analyses of Colorectal Cancer Screening in Europe: Have Studies Included Optimal Screening Intensities?	8
Does the Choice of Health Metric, DALY or QALY, Influence Conclusions of Health Economic Evaluation? A Case Study of Rotavirus Vaccine in Burundi	8
Cost-Effectiveness of Anti-retroviral Adherence Interventions for People Living with HIV: A Systematic Review of Decision Analytical Models	8
The Health Economics of Genomic Technologies: A Growing Evidence Base on Value	7
Effect of Competition on Generic Drug Prices	7
Cost-Effectiveness of Once-Weekly Semaglutide 1 mg versus Canagliflozin 300 mg in Patients with Type 2 Diabetes Mellitus in a Canadian Setting	7
Measurement of Catastrophic Health Expenditure in India: A Systematic Review and Meta-Analysis	7
Information Asymmetry in Hospitals: Evidence of the Lack of Cost Awareness in Clinicians	7
Productivity Loss and Indirect Costs for Patients Newly Diagnosed with Early- versus Late-Stage Cancer in the USA: A Large-Scale Observational Research Study	7
The Effects of School Closures on COVID-19: A Cross-Country Panel Analysis	7
Willingness to Pay for National Health Insurance: A Contingent Valuation Study Among Patients Visiting Public Hospitals in Melaka, Malaysia	7
Use of Cost-Effectiveness Thresholds in Healthcare Public Policy: Progress and Challenges	7
Analysing the Efficiency of Health Systems: A Systematic Review of the Literature	7
Sedaconda ACD-S for Sedation with Volatile Anaesthetics in Intensive Care: A NICE Medical Technologies Guidance	7
Comparing Preferences for Disease Profiles: A Discrete Choice Experiment from a US Societal Perspective	7
The Broader Opportunity Costs in the Broader Cost-Effectiveness Analysis Framework	7
Forecasting the Incremental Value to Society Created by a Class of New Prescription Drugs: A Proposed Methodology and Its Application to Treating Chronic Hepatitis C in India	6
The Limitations and Potentials of Evaluating Economic Aspects of Community-Based Health Promotion: A Critical Review	6
EQ-5D-5L Population Norms for Italy	6
From Spreadsheets to Script: Experiences From Converting a Scottish Cardiovascular Disease Policy Model into R	6
A Systematic Review of Health Economic Evaluations and Budget Impact Analyses to Inform Healthcare Decision-Making in Central America	6

Societal Cost of Racial Pneumococcal Disease Disparities in US Adults Aged 50 Years or Older	6
Cost-effectiveness Analysis of the Dental RECUR Pragmatic Randomized Controlled Trial: Evaluating a Goal-oriented Talking Intervention to Prevent Reoccurrence of Dental Caries in Children	6
Estimating a Drug’s Price After Loss of Exclusivity as a Function of Its Cost of Goods Sold	6
The Impact of Value-Based Payment Models for Networks of Care and Transmural Care: A Systematic Literature Review	6
How Effective is Marginal Healthcare Expenditure? New Evidence from England for 2003/04 to 2012/13	6
Using Genomic Heterogeneity to Inform Therapeutic Decisions for Metastatic Colorectal Cancer: An Application of the Value of Heterogeneity Framework	6
A Head-On Comparison of EQ-VT- and Crosswalk-Based EQ-5D-5L Value Sets	6
Authors’ Reply to Sprengholz and Betsch: “Willingness to Pay for a COVID-19 Vaccine”	6
Headroom Analysis for Early Economic Evaluation: A Systematic Review	6
A Review of Web-Based Tools for Value-of-Information Analysis	6
Model-Based Economic Evaluations of Interventions for Dementia: An Updated Systematic Review and Quality Assessment	6
Estimated Carbon Savings from Changing Surgical Trends in Primary Elective Total Hip Arthroplasty in England: A Retrospective Observational Study	6
Systematic Literature Review of Guidelines on Budget Impact Analysis for Health Technology Assessment	5
Exploring Consumer Preferences for Cannabis Vaping Products to Support Public Health Policy: A Discrete Choice Experiment	5
Modelled Distributional Cost-Effectiveness Analysis of Childhood Obesity Interventions: A Demonstration	5
Health Reform in Aotearoa New Zealand: Insights on Health Equity Challenges One Year On	5
New Horizons? Assessing General Public Preferences for a Wellbeing Economy in the Post-COVID-19 World	5
Acknowledgement to Referees	5
Discrete Choice Experiments in Health State Valuation: A Systematic Review of Progress and New Trends	5
Should Hungary Pay More for a QALY Gain than Higher-Income Western European Countries?	5
How Did the Affordable Care Act Affect Risky Health Behaviors?	5
Are Estimates of the Health Opportunity Cost Being Used to Draw Conclusions in Published Cost-Effectiveness Analyses? A Scoping Review in Four Countries	5
Use of Decision-Analytic Modelling to Assess the Cost-Effectiveness of Diagnostic Imaging of the Spine, Shoulder, and Knee: A Scoping Review	5
Comparison of Prices and Affordability of Cancer Medicines in 16 Countries in Europe and Latin America	5
Cost-Effectiveness and Value of Information Analysis of an Ambient Intelligent Geriatric Management (AmbIGeM) System Compared to Usual Care to Prevent Falls in Older People in Hospitals	5
Quality-Adjusted Life Expectancy Norms Based on the EQ-5D-5L and SF-6Dv2 for China	4
Cost Effectiveness of Molecular Diagnostic Testing Algorithms for the Treatment Selection of Frontline Ibrutinib for Patients with Chronic Lymphocytic Leukemia in Australia	4
Cost Effectiveness of Deep Brain Stimulation for Parkinson’s Disease: A Systematic Review	4
Cost-Utility Analysis of TNF-α Inhibitors, B Cell Inhibitors, and JAK Inhibitors Versus csDMARDs for Rheumatoid Arthritis Treatment	4
Towards a Broader Assessment of Value in Vaccines: The BRAVE Way Forward	4
Genetic Test Utilization and Cost among Families of Children Evaluated for Genetic Conditions: An Analysis of USA Commercial Claims Data	4
Economic Evaluations of Preventive Interventions for Dental Caries and Periodontitis: A Systematic Review	4
Population-Based Testing for Undiagnosed Hepatitis C: A Systematic Review of Economic Evaluations	4
Preferred Attributes of Care Pathways for Obstructive Sleep Apnoea from the Perspective of Diagnosed Patients and High-Risk Individuals: A Discrete Choice Experiment	4
Economic Consequences of Anti-HCV Treatment of Patients Diagnosed Through Screening in Italy: A Prospective Modelling Analysis	4
Using Economics to Impact Local Obesity Policy: Introducing the UK Centre for Economics of Obesity (CEO)	4
Utilising Health Technology Assessment to Develop Managed Access Protocols to Facilitate Drug Reimbursement in Ireland	4
Review and Assessment of Policy Options for Improving Access to Combination Therapies in Oncology in Europe	4
Economic Evaluation of Oral Nucleos(t)ide Analogues for Patients with Chronic Hepatitis B in Thailand	4
The Value of New: Consideration of Product Novelty in Health Technology Assessments of Pharmaceuticals	4
Economic Epidemiology: A Framework to Study Interactions of Epidemics and the Economy	4
Comparison of the Measurement Properties of EQ-5D-5L and SF-6Dv2 in COVID-19 Patients in China	4
Productivity Losses due to Health Problems Arising from COVID-19 Pandemic: A Systematic Review of Population-Level Studies Worldwide	4
Correction to: Cost-Effectiveness of Once-Weekly Semaglutide 1 mg versus Canaglifozin 300 mg in Patients with Type 2 Diabetes Mellitus in a Canadian Setting	4
A Model-Based Estimate of the Cost-Effectiveness Threshold in Germany	4
Correction: Economic Evaluations of Robotic-Assisted Surgery: Methods, Challenges and Opportunities	4
A Case Study on Reviewing Specialist Services Commissioning in Wales: TAVI for Severe Aortic Stenosis	3
Financing and Reimbursement Models for Personalised Medicine: A Systematic Review to Identify Current Models and Future Options	3
Costs and Cost-Effectiveness of User-Testing of Health Professionals’ Guidelines to Reduce the Frequency of Intravenous Medicines Administration Errors by Nurses in the United Kingdom: A Probabilistic	3
Value is Gendered: The Need for Sex and Gender Considerations in Health Economic Evaluations	3
Predicting Health Utilities Using Health Administrative Data: Leveraging Survey-linked Health Administrative Data from Ontario, Canada	3
The Assessment of Patient-Reported Outcomes for the Authorisation of Medicines in Europe: A Review of European Public Assessment Reports from 2017 to 2022	3
Economic Evaluation of COVID-19 Immunization Strategies: A Systematic Review and Narrative Synthesis	3
Modelling Informal Carers’ Health-Related Quality of Life: Challenges for Economic Evaluation	3
Evolving Evidence-Based Value Assessment of One-Time Therapies: Tisagenlecleucel as a Case Study	3
Beyond the Diagnosis: Valuing Genome-Wide Sequencing for Rare Disease Diagnosis Using Contingent Valuation	3
myCOPD App for Managing Chronic Obstructive Pulmonary Disease: A NICE Medical Technology Guidance for a Digital Health Technology	3
Evaluating the Short-Term Costs and Benefits of a Nationwide Diabetes Prevention Programme in England: Retrospective Observational Study	3
Alternative Payment Models for Innovative Medicines: A Framework for Effective Implementation	3
Acknowledgement to Referees	3
Estimating Transition Probabilities for Modeling Major Depression in Adolescents by Sex and Race or Ethnicity Combinations in the USA	3
Informing Structural Assumptions for Three State Oncology Cost-Effectiveness Models through Model Efficiency and Fit	3
Cost Effectiveness of Pharmacological Management for Osteoarthritis: A Systematic Review	3
The Short Form 6 Dimensions (SF-6D): Development and Evolution	3
Cost Effectiveness of Adding Fenfluramine to Standard of Care for Patients with Dravet Syndrome in Sweden	3
The Cost-Effectiveness of Adjunctive Lifestyle Interventions for the Management of Cancer: A Systematic Review	3
How Does the New Australian EQ-5D-5L Value Set Impact Utility Scores? Analysis of Data from the Australian Orthopaedic Association National Joint Replacement Registry	3
How Much Money Should be Paid for a Patient to Isolate During the COVID-19 Outbreak? A Discrete Choice Experiment in Iran	3
Is the Use of Unanchored Matching-Adjusted Indirect Comparison Always Superior to Naïve Indirect Comparison on Survival Outcomes? A Simulation Study	2
An Investigation into the Relationship Between Choice of Model Structure and How to Adjust for Subsequent Therapies Using a Case Study in Oncology	2
Economic Evaluation of a Tumour-Agnostic Therapy: Dutch Economic Value of Larotrectinib in TRK Fusion-Positive Cancers	2
The Gift of Time, How Do I Want to Spend It? Exploring Preferences for Time Allocation Among Women with and without a Breast Cancer Diagnosis	2
Rationing in an Era of Multiple Tight Constraints: Is Cost-Utility Analysis Still Fit for Purpose?	2
Episcissors-60 for Mediolateral Episiotomy: Evaluation of Clinical and Economic Evidence to Inform NICE Medical Technologies Guidance	2
Compulsory Licensing as an Instrument to Tackle High Medicine Prices: A Realist Review of Industrial and Health Consequences	2
Methods and Practical Considerations for Conducting Budget Impact Analysis for Non-Pharmaceutical Interventions	2
Cost-Effectiveness Analysis of Stockholm 3 Testing Compared to PSA as the Primary Blood Test in the Prostate Cancer Diagnostic Pathway: A Decision Tree Approach	2
UroLift for Treating Lower Urinary Tract Symptoms of Benign Prostatic Hyperplasia: A NICE Medical Technology Guidance Update	2
The Economic Impact of Community Paramedics Within Emergency Medical Services: A Systematic Review	2
Using Constrained Optimization for the Allocation of COVID-19 Vaccines in the Philippines	2

Financial Incentives in the Path to Recovery from the COVID-19 Pandemic	2
Australian Preferences for Prenatal Screening: A Discrete Choice Experiment Comparing Metropolitan and Rural/Regional Areas	2
The Hidden Toll of Psychological Distress in Australian Adults and Its Impact on Health-Related Quality of Life Measured as Health State Utilities	2
A Contingent Valuation Study for Use in Valuing Public Goods with Health Externalities: The Case of Street Pianos	2
Comment on: “10 Years of AMNOG: What is the Willingness-to-Pay for Pharmaceuticals in Germany?”	2
Cost Effectiveness of Ribociclib and Palbociclib in the Second-Line Treatment of Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer in Post-Menopausal Indian Women	2
Cost of Carbon in the Total Cost of a Healthcare Procedure: Example of Micro-Costing Study in a French Setting	2
Economic Evaluation of an Intervention Designed to Reduce Bullying in Australian Schools	2
Health Interventions May Have Divergent Impacts on Health and Economic Equity: A Case Study of the Community-Based Hypertension Improvement Project in Ghana	2
Budget Impact Analysis of the FreeStyle Libre Flash Continuous Glucose Monitoring System® in Patients with Type 1 Diabetes Mellitus and Type 2 Diabetes Mellitus with Multiple Daily Insulin Injections	2
Cost-Utility Analysis of Major System Change in Specialist Cancer Surgery in London, England, Using Linked Patient-Level Electronic Health Records and Difference-in-Differences Analysis	2
Are Drug Novelty Characteristics Associated With Greater Health Benefits?	2
Measurement of Health-Related Quality of Life from Conception to Postpartum Using the EQ-5D-5L Among a National Sample of US Pregnant and Postpartum Adults	2